Harm Reduction Studies

Perceived relative harm of using e-cigarettes predicts future product switching among US adult cigarette and e-cigarette dual users

Date Added:
July 12, 2024

US adult dual users of e-cigarettes and cigarettes who perceive e-cigarettes as less harmful than cigarettes appear to be more likely to switch to exclusive e-cigarette use, more likely to remain dual users and less likely to switch to exclusive cigarette use 1 year later than dual users with other perceptions of e-cigarette harm.

Relative Harm Perceptions of E-Cigarettes Versus Cigarettes, U.S. Adults, 2018–2020

Date Added:
July 12, 2024

Perceptions of E-cigarettes as more harmful than cigarettes increased sharply between 2019 and 2020. Increases in tobacco product use were potentially guided by product-specific relative harm perceptions because changes occurred primarily in individuals who perceived their preferred product as relatively less harmful, suggesting the need for accurate messaging of relative and absolute product risks

Balancing Consideration of the Risks and Benefits of E-Cigarettes

Date Added:
July 11, 2024

A review of the health risks of e-cigarette use, the likelihood that vaping increases smoking cessation, concerns about youth vaping, and the need to balance valid concerns about risks to youths with the potential benefits of increasing adult smoking cessation.

The Vilification of Vaping

Date Added:
July 11, 2024

Harm reduction is the keystone. To this end, and to ensure that the downward trend in cigarette sales continues, policymakers need to enact measures that will simultaneously limit access to teens and induce smokers to switch to vaping products.

Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model

Date Added:
July 5, 2024

Smoking prevalence in Canada, especially among younger adults, declined more rapidly once NVPs became readily available. The emergence of NVPs into the Canadian marketplace has not slowed the decline in smoking. NVP-related 2012–2020 smoking reductions yielded 100,000 smoking-attributable deaths averted from 2012 to 2060.